Peng Cui

机构：Burning Rock Biotech (China) · ORCID：0000-0001-8465-4164

发表论文 25 篇 · 总被引 1066 次 · h-index 13

代表论文

• Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma (2021 · Cancer Cell · 被引 433)
• Circulating cell-free DNA for cancer early detection (2022 · The Innovation · 被引 160)
• Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology (2023 · Science Translational Medicine · 被引 134)
• miR‐216a may inhibit pancreatic tumor growth by targeting JAK2 (2015 · FEBS Letters · 被引 61)
• Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma (2024 · Nature Medicine · 被引 58)
• Identification of human circadian genes based on time course gene expression profiles by using a deep learning method (2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 32)